Pneumococcal; tetanus, diphtheria, and pertussis; and influenza vaccination increased among high-risk adults in a 2-year study. Results: Based on International Classification of Diseases, Ninth ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that the data from its two pivotal Phase 3 immunogenicity and safety trials of Prevnar 13®* (Pneumococcal 13-valent Conjugate Vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results